Ascendia

 

  MARKET NEWS

 

Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program
Bracco Launches BubbleGen Early Access Program for Microbubble-Based Cell Selection & Activation at ISCT
Single-Cell Multiomics Enables High-Resolution Vector Copy Number Profiling in CAR-T Therapie
Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

  EXPERT CONTENT & RESOURCES

Avoiding Recalls: How to Ensure Sterility in Ophthalmic Products

Avoiding Recalls: How to Ensure Sterility in Ophthalmic Products

In the wake of several high-profile eye drop recalls, we look at the challenges of achieving sterility in ophthalmic products, the consequences of failing to do so, and how AbbVie Contract Manufacturing ensures product sterility and safety.

On-Demand Presentation: Analytical Strategy & Challenges for ADC

On-Demand Presentation: Analytical Strategy & Challenges for ADC

Global Vice President of Analytical & Research Development, Scott Zugel, spoke at Veranova’s SCALE Symposium, where he outlined key analytical strategies and challenges in ADC manufacturing in the pharmaceutical industry.

Portrait of Bryn L. Dubin

America’s Next Healthcare Crisis Is Already Here - And We’re Not Ready

Bryn L. Dubin, Master’s Student at the LBJ School of Public Affairs studying health and economic policy. Dubin has federal and state legislative and policy analysis experience.

INTERVIEW - Advancing Regenerative Medicine for Chronic Disease

INTERVIEW - Advancing Regenerative Medicine for Chronic Disease

Lance Alstodt, CEO of BioRestorative Therapies, discusses the development of its lead cell therapy candidate BRTX-100, the evolving regulatory and manufacturing landscape for autologous therapies, and how regenerative platforms could reshape treatment paradigms for chronic conditions.

  FEATURED EDITORIAL

Drug Development & Delivery

  COMPANY PROFILE

Sharp is a leading global provider of commercial packaging, clinical supply services and sterile manufacturing solutions for the pharmaceutical and biotechnology industries. For over 70 years, we have partnered with clients across every phase of the drug development journey — from early-phase clinical trials through to commercial launch and lifecycle management. Our mission is to support our clients in delivering life-changing therapies safely, efficiently and compliantly to patients worldwide. Click here for more.

  WHITEPAPERS & WEBINARS

WHITEPAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development

WHITEPAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development

Why Early Development Requires a Different Decision Model

Early oral drug development is an exercise in working under constraint. Teams are asked to make consequential decisions when materials are limited, timelines are tight, and the data are incomplete. Traditionally, formulation …

WHITEPAPER - Small Molecules: Choosing the Right Development Path

WHITEPAPER - Small Molecules: Choosing the Right Development Path

Summary

The white paper, Small Molecules: Choosing the Right Development Path, outlines a structured, risk-minimized approach to early CMC (Chemistry, Manufacturing, and Controls) development for small-molecule drugs—particularly for startups and virtual pharma companies with limited resources.

Key messages:

  • Start
…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 13 – Capsules
May 20 – Injection Devices